The 1st DADI newsletter has been published on the EMA website!
The digital application dataset integration (DADI) newsletter is published four times a year and provides pharmaceutical companies and the national competent authorities in the EU updates on the progress of the DADI project.
This first issue covers topics such as:
• DADI and PMS overview
• Updated roadmap for DADI as the scope of the October 2022 Go-live will be limited to CAPs
• User Acceptance Testing (UAT) for Human Variations Form with a selected group of testers to be conducted between 5 September and 16 September 2022
Additionally, we would like to remind you that the next DADI and Q&A public webinar will be held on Friday, 2 September 2022 (Link to registration)